Literature DB >> 6288857

Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV).

K Shiraki, T Okuno, K Yamanishi, M Takahashi.   

Abstract

Varicella-zoster virus (VZV), labelled with [35S]methionine or [14C]glucosamine, was purified by centrifugation through sucrose gradients followed by equilibrium centrifugation in CsCl, and analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). At least 32 polypeptides ranging in mol. wt. from approx. 280 X 10(3) to 21.5 X 10(3) (280K to 21.5K) and six glycopeptides ranging in mol. wt. from approx. 115K to 45K (gp1 to gp6) were found in the virion. The immunological relationship of VZV and herpes simplex virus (HSV) was investigated. In neutralization (NT) tests, no cross-neutralization was observed between VZV and HSV-1 or -2. In fluorescent antibody staining, however, a cross-reaction was observed between VZV- and HSV-1-infected human embryonic lung (HEL) cells and heterologous antiserum. When cross-reactions were investigated by immunoprecipitation followed by SDS-PAGE, several cross-reacting polypeptides were discovered. Cross-reacting glycopeptides of 64K (gp3) and 55K (gp5) were isolated from VZV-infected cell lysates by affinity column chromatography to immobilized HSV-1 antibodies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288857     DOI: 10.1099/0022-1317-61-2-255

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

Authors:  C M Edson; B A Hosler; R A Respess; D J Waters; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies.

Authors:  B Forghani; K W Dupuis; N J Schmidt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

5.  Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3.

Authors:  A Vafai; Z Wroblewska; M Wellish; M Green; D Gilden
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals.

Authors:  K A Clouse; P W Adams; C G Orosz
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

7.  Characterization of neutralizing epitopes of varicella-zoster virus glycoprotein H.

Authors:  Yasushi Akahori; Kazuhiro Suzuki; Tohru Daikoku; Masae Iwai; Yoshihiro Yoshida; Yoshizo Asano; Yoshikazu Kurosawa; Kimiyasu Shiraki
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography.

Authors:  W E Friedrichs; C Grose
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

10.  Antibody to varicella-zoster virus immediate-early protein 62 augments allodynia in zoster via brain-derived neurotrophic factor.

Authors:  Yuka Hama; Kimiyasu Shiraki; Yoshihiro Yoshida; Atsushi Maruyama; Makoto Yasuda; Masaaki Tsuda; Mariko Honda; Michiaki Takahashi; Hiroshi Higuchi; Ichiro Takasaki; Tohru Daikoku; Tadaharu Tsumoto
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.